Finelidone is an oral drug, which is a third-generation powerful non-steroidal highly selective salt-corticosteroid receptor antagonist (MRA) with high selectivity and strong affinity, and can effectively block the effect of aldosterone on MR (aldosterone receptor), thus playing a role in reducing blood pressure and reducing cardiac burden. In addition, it can also have an inhibitory effect on inflammation, fibrosis and so on, delaying the damage to the kidney structure and function, so it is widely used in the treatment of heart failure, diabetic nephropathy and other diseases.
However, finelidone can also cause some side effects. Common side effects include headache, nausea, vomiting, diarrhea, and low blood pressure. In the course of use, there may also be abnormal liver function, electrolyte disorders, kidney damage and other side effects. In addition, due to the high selectivity of finelidone to MR, the use of the process may also inhibit the normal aldosterone-receptor interaction, thus affecting some physiological functions of the human body.
Therefore, in the process of using finelidone, it is necessary to pay attention to the occurrence of adverse reactions, especially when headache, low blood pressure, liver and kidney function abnormalities, etc., should be stopped in time and consult a doctor. At the same time, it is also necessary to pay attention to the interaction with other drugs to avoid the occurrence of adverse reactions.
In general, finelidone, as a new type of cardiovascular drugs, has a good role in reducing blood pressure and reducing cardiac burden, and is expected to play an important role in the treatment of heart failure, diabetic nephropathy and other diseases, but at the same time, it is necessary to pay close attention to the occurrence of side effects to ensure the treatment effect and safety.
